PMID: 42575111

Efficacy and safety of once-weekly semaglutide 2·4 mg in Chinese adults with overweight or obesity (STEP 12): a randomised, double-blind, placebo-controlled, multicentre, phase 3b trial.

Guo Lixin, Bao Xiaolei, Huang Kuo-Chin, Kolnes Kristoffer Jensen, Laugesen Christian, Lu Yibing, Luo Bifen, Yuan Guoyue, Kushner Robert F

The lancet. Diabetes & endocrinology · 2026

This entry links to third-party literature. For research use only.

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.

Efficacy and safety of once-weekly semaglutide 2&#xb7;4 mg in Chinese adults with overweight or obesity (STEP 12): a randomised, double-blind, placebo-controlled, multicentre, phase 3b trial.